Locoregional Radiotherapy Improves Survival Outcomes in Patients With De Novo Metastatic Nasopharyngeal Carcinoma Receiving Chemoimmunotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
ESMO Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Locoregional radiotherapy improves survival outcomes in de novo metastatic nasopharyngeal carcinoma treated with chemoimmunotherapy
ESMO Open 2023 Sep 01;8(5)101629, YJ Hu, TZ Lu, H Zhang, M Fang, BJ Chen, QJ Guo, SJ Lin, P Feng, Y Wang, TC Jiang, XC Gong, JJ Pan, JG Li, YF XiaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.